<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001143313</cik>
        <entityName>NYSE MKT LLC</entityName>
    </exchange>

    <issuer>
        <cik>0000926844</cik>
        <entityName>China Botanic Pharmaceutical</entityName>
        <fileNumber>001-34808</fileNumber>
        <address>
            <street1>Level 11, Changjiang Intl Bldg, No 28</street1>
            <street2>Changjian Road, Nangang District</street2>
            <city>Harbin, Heilongjing Province</city>
            <stateOrCountryCode>F4</stateOrCountryCode>
            <stateOrCountry>CHINA</stateOrCountry>
            <zipCode>150090</zipCode>
        </address>
        <telephoneNumber>86-451-5762-0378</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock, $0.001 par value</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(b)</ruleProvision>

    <signatureData>
        <signatureName>Janice O'Neill</signatureName>
        <signatureTitle>Senior Vice President, Corporate Compliance</signatureTitle>
        <signatureDate>2013-06-20</signatureDate>
    </signatureData>
</notificationOfRemoval>
